Selective ophthalmic artery chemotherapy with melphalan shows promise for retinoblastoma
- Posted on: Sep 15 2021
- Leave a response
Phase 2 results show that selective ophthalmic artery chemotherapy with melphalan can be used as a first-line therapy for retinoblastoma.
Source: AAO
Posted in: Uncategorized